drugset / Trial / NCT00182442

Cognition, Functioning and Quality of Life

NCT00182442

RandomizedParallel-groupOpen-labelTreatment

Summary

People affected by schizophrenia often experience poor concentration, lapses in memory and difficulty with completing tasks; and this set of problems are known as neuro-cognitive deficits. Traditional medications used in the treatment of schizophrenia have not been particularly useful in improving these problems, while the recently introduced medications are expected to be superior in this respect. The proposed research study is designed to assess the effect of two of the new medications (Zyprexa and Seroquel) in improving the neurocognitive deficits associated with schizophrenia.

Timeline

Start
2003-10
Primary completion
Completion
2006-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Olanzapine Small molecule
Subject Quetiapine Small molecule

Indications